RE: You just had to know..NCI is testing PhG-alpha-1 against a 60 cell panel of Cancers, including tumours that we already know from PharmaGap testing last year were reduced or eliminated by the drug. If you trust the scientists at PharmaGap then you already know that at least 2 of the results will be positive with another 58 chances for success.
In addition, PharmaGap has the testing going on at OHRI, a collaboration with MD Biosciences and another 6 drug compounds in line after PhG-alpha-1.
It is absurd to think this stock is going to get cut at least in half (.075) or only go up to .25 to .30 range on news of NCI results.